Product
Ceftolozane-Tazobactam
1 clinical trial
1 indication
Indication
Febrile NeutropeniaClinical trial
Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase (ESBL)-Producing Pathogens: a Randomized Double-blind Non-inferiority Trial.Status: Not yet recruiting, Estimated PCD: 2025-04-01